Mumbai: Sun Pharmaceutical Industries has got nod from USFDA to promote the generic version of Novartis’s Exelon capsules ‘Rivastigmine Tartrate.’

Rivastigmine Tartrate is used for the treatment of Alzheimer’s and Parkinson’s disease.

Sun gets FDA authorization for 1.5mg, 3mg, 4.5mg and 6mg drug potencies.

The yearly sales of Exelon capsules in the US market would be around $200 million in these strengths.

Chennai-based firm, Sun TV Network has announced better-than-expected re

Kolkata: ITC Ltd, Indian market leader has entered into an agreement with Nagal

Mumbai: Putting an end to conjectures, Reliance Power Limited has made declaration that that its plan

The SEBI’s meeting with foreign institutional investors (FIIs) had cleared the fundamental point that the attempts to make out unknown investments via participatory notes (PNs) will carry on till t